IX Biopharma Company Announcements (42C)

SGX Google Yahoo News TradingView

IX BIOPHARMA LTD. (42C) SGD 0.122 +0.00% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2025-12-04

Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants

2025-11-27

Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants

2025-11-19

Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants

2025-11-09

General Announcement::Press Release - iX Biopharma Secures US Partner to Accelerate Commercialisation of WaferiX Portfolio

2025-11-06

Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants

2025-11-05

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Eddy Lee Yip Hang

2025-11-05

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Anson Properties Pte. Ltd.

2025-10-31

General Announcement::Press Release - iX Biopharma Raises S$6.7 Million to Accelerate U.S. Expansion

2025-10-30

Placements::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Receipt of LQN

2025-10-28

General Announcement::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Entry Into Placement Agreement

2025-10-28

Placements::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Results of Proposed Placement

2025-10-27

Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants

2025-10-24

REPL::Annual General Meeting::Voluntary

2025-10-22

Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants

2025-10-07

Annual General Meeting::Voluntary

2025-08-29

Financial Statements and Related Announcement::Full Yearly Results

2025-07-03

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

2025-03-24

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Teo Woon Keng John

2025-03-24

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

2025-03-24

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Patrick Donald Davies

2025-03-21

General Announcement::Issuance and Allotment of Directors' Shares

2025-03-10

REPL::Extraordinary/ Special General Meeting::Voluntary

2025-02-22

Extraordinary/ Special General Meeting::Voluntary

2025-02-21

Equity Listing - Ordinary Shares::Issue and Allotment of New Shares Pursuant to iX Performance Share Plan

2025-02-14

Employee Stock Option/ Share Scheme::Grant of Share Awards Pursuant to iX Performance Share Plan

2025-02-07

Financial Statements and Related Announcement::Half Yearly Results

2024-11-15

General Announcement::Minutes of Annual General Meeting Held on 17 October 2024

2024-10-17

REPL::Extraordinary/ Special General Meeting::Voluntary

2024-10-17

REPL::Annual General Meeting::Voluntary

2024-09-30

Financial Statements and Related Announcement::Auditor's Comments of Accounts

2024-09-30

Annual General Meeting::Voluntary

2024-09-30

Change - Announcement of Cessation::Retirement of Independent Director

2024-09-30

Extraordinary/ Special General Meeting::Voluntary

2024-08-12

General Announcement::Press Release - New Study Highlights CBD Wafer's Potential in Kidney Failure Patients

2024-07-24

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

2024-07-22

REPL::Rights::Voluntary

2024-07-19

General Announcement::Issue and Listing of the Rights Shares and the Warrants

2024-07-15

General Announcement::Notice From Undertaking Shareholder Anson Properties Pte. Ltd.

2024-07-09

General Announcement::Press Release - Breakthrough Sublingual Wafers Raise NAD+ Levels, Enhance Well-Being in Human Trial

2024-07-02

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

2024-07-02

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

2024-07-01

General Announcement::Proposed Renounceable Non-Underwritten Rights Cum Warrants Issue: Despatch of Notification and Forms

2024-06-26

REPL::Rights::Voluntary

2024-06-18

General Announcement::Notice of Adjustment to Conversion Price of 9% Convertible Bonds Principal Amount S$2 Million

2024-06-18

REPL::Rights::Voluntary

2024-06-11

REPL::Rights::Voluntary

2024-06-06

Rights::Voluntary

2024-03-20

General Announcement::Update For Shareholders

2024-03-11

General Announcement::Press Release - iX Biopharma Announces Development of Semaglutide Sublingual Wafer, iXB 401

2024-03-04

General Announcement::Press Release - iX Biopharma Unveils Novel NAD Wafers

© 2025 Dividends.sg / More Countries